Literature DB >> 23312337

Intraluminal crawling versus interstitial neutrophil migration during inflammation.

Robert Pick1, Doris Brechtefeld, Barbara Walzog.   

Abstract

Site-directed trafficking of polymorphonuclear neutrophils (PMN) to their target regions within the tissue is an important prerequisite for efficient host defense during the acute inflammatory response. This process requires intraluminal crawling of PMN on the activated endothelial cells to their extravasation sites. Upon transendothelial diapedesis, PMN migrate in the interstitial tissue to sites of inflammation. These crucial steps within the recruitment cascade are defined as intraluminal crawling and interstitial migration. In this review, we will focus on the molecular mechanisms that control and fine-tune these migratory processes and discuss the role of adhesion molecules of the β2 integrin (CD11/CD18) family for these cellular functions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312337     DOI: 10.1016/j.molimm.2012.12.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

Review 1.  The multifaceted functions of neutrophils.

Authors:  Tanya N Mayadas; Xavier Cullere; Clifford A Lowell
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

Review 2.  Neutrophil migration: moving from zebrafish models to human autoimmunity.

Authors:  Miriam A Shelef; Sebastien Tauzin; Anna Huttenlocher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

Review 3.  The regulatory role of serum response factor pathway in neutrophil inflammatory response.

Authors:  Ashley Taylor; Stephanie Halene
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

4.  SRF is required for neutrophil migration in response to inflammation.

Authors:  Ashley Taylor; Wenwen Tang; Emanuela M Bruscia; Ping-Xia Zhang; Aiping Lin; Peter Gaines; Dianqing Wu; Stephanie Halene
Journal:  Blood       Date:  2014-02-26       Impact factor: 22.113

5.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

6.  Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers.

Authors:  Daniela Krause; Andrea Jobst; Franka Kirchberg; Susann Kieper; Kristin Härtl; Ralph Kästner; Aye-Mu Myint; Norbert Müller; Markus J Schwarz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-05       Impact factor: 5.270

7.  Multifactorial assessment of neutrophil chemotaxis efficiency from a drop of blood.

Authors:  Felix Ellett; Anika L Marand; Daniel Irimia
Journal:  J Leukoc Biol       Date:  2022-01-31       Impact factor: 6.011

Review 8.  Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation.

Authors:  Michael Schnoor; Pilar Alcaide; Mathieu-Benoit Voisin; Jaap D van Buul
Journal:  Mediators Inflamm       Date:  2015-10-19       Impact factor: 4.711

Review 9.  Regulators and Effectors of Arf GTPases in Neutrophils.

Authors:  Jouda Gamara; François Chouinard; Lynn Davis; Fawzi Aoudjit; Sylvain G Bourgoin
Journal:  J Immunol Res       Date:  2015-11-02       Impact factor: 4.818

10.  Anti-inflammatory activity of aqueous extract and bioactive compounds identified from the fruits of Hancornia speciosa Gomes (Apocynaceae).

Authors:  Manoela Torres-Rêgo; Allanny Alves Furtado; Mariana Angélica Oliveira Bitencourt; Maira Conceição Jerônimo de Souza Lima; Rafael Caetano Lisbôa Castro de Andrade; Eduardo Pereira de Azevedo; Thaciane da Cunha Soares; José Carlos Tomaz; Norberto Peporine Lopes; Arnóbio Antônio da Silva-Júnior; Silvana Maria Zucolotto; Matheus de Freitas Fernandes-Pedrosa
Journal:  BMC Complement Altern Med       Date:  2016-08-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.